NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis
A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis

NCT05565560

Active Not RecruitingPhase 3

Sponsor: Amgen

Conditions: Plaque Psoriasis

Interventions: Apremilast

Countries: Japan

The primary objective of this study is to evaluate the efficacy of apremilast in children and adolescents (ages 6 through 17 years) with moderate to severe plaque psoriasis.

Eligibility overview

Sex: ALL

Age: 6 Years to 17 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Japanese participants aged 6 to 17 years at screening
* Participants must have a weight of ≥ 15 kg
* Diagnosis of chronic plaque psoriasis for at least 3 months prior to screening
* Has moderate to severe plaque psoriasis at screening and baseline as defined by:
* PASI score ≥ 12; and
* BSA ≥ 10; and
* sPGA ≥ 3 (moderate to severe)
* Disease inadequately controlled by or contraindicated for ≥ 1 topical therapy for psoriasis
* Candidate for systemic therapy or phototherapy

Exclusion Criteria:

* Psoriasis flare or rebound within 4 weeks prior to screening
* Evidence of skin conditions, other than psoriasis, that would interfere with clinical assessments
* Other than psoriasis, history of any clinically significant (as determined by the investigator) cardiac, endocrinologic, pulmonary, neurologic, psychiatric, hepatic, renal, hematologic, immunologic disease, or other major uncontrolled disease
* Prior history of suicide attempt at any time in the participant's lifetime prior to screening or baseline in the study, or major psychiatric illness requiring hospitalization within 3 years prior to signing the assent and informed consent
* Guttate, erythrodermic, or pustular psoriasis at screening and baseline
Locations (29)
  • Nagoya, Aichi-ken, Japan
  • Fukuoka, Fukuoka, Japan
  • Kitakyushu-shi, Fukuoka, Japan
  • Kurume-shi, Fukuoka, Japan
  • Fukushima, Fukushima, Japan
  • Gifu, Gifu, Japan
  • Maebashi, Gunma, Japan
  • Obihiro-shi, Hokkaido, Japan
  • Sapporo, Hokkaido, Japan
  • Kahoku-gun, Ishikawa-ken, Japan
  • Marugame-shi, Kagawa-ken, Japan
  • Takamatsu, Kagawa-ken, Japan
  • Kagoshima, Kagoshima-ken, Japan
  • Isehara-shi, Kanagawa, Japan
  • Kawasaki-shi, Kanagawa, Japan
  • Kyoto, Kyoto, Japan
  • Matsumoto-shi, Nagano, Japan
  • Nagasaki, Nagasaki, Japan
  • Ginowan-shi, Okinawa, Japan
  • Hirakata-shi, Osaka, Japan
  • Osaka, Osaka, Japan
  • Osakasayama-shi, Osaka, Japan
  • Shimotsuga-gun, Tochigi, Japan
  • Utsunomiya, Tochigi, Japan
  • Chuo-ku, Tokyo, Japan
  • Itabashi-ku, Tokyo, Japan
  • Minato-ku, Tokyo, Japan
  • Shinjuku-ku, Tokyo, Japan
  • Shinjyuku-ku, Japan